Metropolitan Life Insurance Company (MetLife)’s PotlatchDeltic PCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,160
Closed -$196K 1519
2024
Q1
$196K Sell
4,160
-397
-9% -$18.3K 0.01% 727
2023
Q4
$224K Hold
4,557
0.01% 683
2023
Q3
$207K Buy
4,557
+193
+4% +$9.53K 0.01% 657
2023
Q2
$231K Buy
4,364
+79
+2% +$3.8K 0.01% 623
2023
Q1
$212K Sell
4,285
-633
-13% -$29.7K 0.01% 648
2022
Q4
$216K Buy
4,918
+106
+2% +$4.8K 0.01% 679
2022
Q3
$197K Buy
4,812
+688
+17% +$31.6K 0.01% 680
2022
Q2
$182K Hold
4,124
0.01% 734
2022
Q1
$217K Sell
4,124
-23,075
-85% -$1.26M 0.01% 779
2021
Q4
$1.64M Sell
27,199
-1,193
-4% -$66.9K 0.02% 645
2021
Q3
$1.46M Sell
28,392
-1,540
-5% -$80.3K 0.02% 697
2021
Q2
$1.59M Buy
29,932
+1,163
+4% +$67K 0.02% 676
2021
Q1
$1.52M Sell
28,769
-254
-0.9% -$13.1K 0.02% 679
2020
Q4
$1.45M Sell
29,023
-1,440
-5% -$66.2K 0.02% 643
2020
Q3
$1.28M Sell
30,463
-963
-3% -$41.2K 0.02% 609
2020
Q2
$1.2M Sell
31,426
-4,654
-13% -$157K 0.02% 628
2020
Q1
$1.13M Sell
36,080
-2,124
-6% -$82.3K 0.02% 621
2019
Q4
$1.65M Sell
38,204
-532
-1% -$22.7K 0.03% 636
2019
Q3
$1.59M Sell
38,736
-192
-0.5% -$7.45K 0.03% 612
2019
Q2
$1.52M Sell
38,928
-68
-0.2% -$2.55K 0.03% 657
2019
Q1
$1.47M Sell
38,996
-340
-0.9% -$12.1K 0.03% 654
2018
Q4
$1.24M Buy
39,336
+3,200
+9% +$114K 0.02% 676
2018
Q3
$1.48M Buy
36,136
+624
+2% +$29.5K 0.03% 698
2018
Q2
$1.81M Buy
35,512
+749
+2% +$38K 0.03% 577
2018
Q1
$1.81M Buy
34,763
+11,568
+50% +$601K 0.03% 592
2017
Q4
$1.16M Sell
23,195
-42,176
-65% -$2.18M 0.02% 823
2017
Q3
$3.33M Sell
65,371
-128
-0.2% -$6.06K 0.02% 776
2017
Q2
$2.99M Buy
65,499
+488
+0.8% +$22.4K 0.02% 820
2017
Q1
$2.97M Sell
65,011
-72
-0.1% -$3.11K 0.02% 824
2016
Q4
$2.71M Sell
65,083
-118
-0.2% -$4.76K 0.02% 863
2016
Q3
$2.54M Sell
65,201
-941
-1% -$35.3K 0.02% 870
2016
Q2
$2.25M Buy
66,142
+1,838
+3% +$62.2K 0.02% 895
2016
Q1
$2.03M Buy
64,304
+1,046
+2% +$29.2K 0.02% 889
2015
Q4
$1.91M Buy
63,258
+147
+0.2% +$4.6K 0.01% 911
2015
Q3
$1.82M Sell
63,111
-1,188
-2% -$39.8K 0.01% 943
2015
Q2
$2.27M Sell
64,299
-915
-1% -$33.8K 0.02% 919
2015
Q1
$2.61M Buy
65,214
+115
+0.2% +$4.66K 0.02% 802
2014
Q4
$2.73M Buy
65,099
+507
+0.8% +$21.3K 0.02% 833
2014
Q3
$2.6M Buy
64,592
+347
+0.5% +$14.5K 0.02% 837
2014
Q2
$2.66M Sell
64,245
-1,180
-2% -$46.3K 0.02% 861
2014
Q1
$2.53M Buy
65,425
+648
+1% +$25.7K 0.02% 858
2013
Q4
$2.7M Buy
64,777
+135
+0.2% +$5.47K 0.02% 818
2013
Q3
$2.56M Buy
64,642
+1,609
+3% +$66.1K 0.02% 804
2013
Q2
$2.55M Buy
+63,033
New +$2.89M 0.02% 754

Other funds holding PCH

Metropolitan Life Insurance Company (MetLife)'s PCH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of PotlatchDeltic (PCH) in Q2 2024, closing a stake of 4,160 shares — an estimated $196K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PCH in Q2 2013 and held it in 44 quarters. The position peaked at $3.33M in Q3 2017. 305 funds tracked by Wall St. Rank hold PCH as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining PotlatchDeltic position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,160 PotlatchDeltic shares in Q2 2024, an estimated $196K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in PotlatchDeltic in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s PotlatchDeltic position peaked at $3.33M in Q3 2017.
  • 305 funds tracked by Wall St. Rank held PotlatchDeltic as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.